Pharming PHAR
NASDAQ PHAR
$13.02 -0.14 (-1.06%)
As of: Nov 10, 2026 · 10:59 AM EST

Pharming (PHAR) Total Debt (2019 - 2024)

Updated

Pharming (PHAR) recorded Total Debt of -$4.25 million in Q4 2024, compared with $2.02 million a year earlier.

Analysis

Pharming (PHAR) Total Debt (2019 - 2024) Analysis & Trends

Starting with Q4 2019, Pharming's Total Debt history includes 12 quarters.

  • Across earlier years, Total Debt came in at $2.02 million in FY2023 (unchanged), $2.02 million in FY2022 (unchanged), $2.02 million in FY2021 (-91.9%) and $25 million in FY2020 (-64.9%).
  • The Q4 2024 figure is the lowest quarterly Total Debt in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 44.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 80.90 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 32.35 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 26.23 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 62.67 Bn
10 Pharming 898.85 Mn 429.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.25 Mn
Jun 30, 2023 91,000.00
Dec 31, 2022 228,000.00
Sep 30, 2022 143,000.00
Jun 30, 2022 223,000.00
Mar 31, 2022 162,000.00
Sep 30, 2021 386,000.00
Jun 30, 2021 189,000.00
Mar 31, 2021 189,000.00
Dec 31, 2020 25.04 Mn
Dec 31, 2019 77.25 Mn
API Access

Pharming Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEY